Supportive Care in Cancer

, Volume 13, Issue 2, pp 117–121 | Cite as

Anticipatory nausea and vomiting

  • Matti S. AaproEmail author
  • Alexander Molassiotis
  • Ian Olver
Original Article


Anticipatory nausea and vomiting (ANV) is not only a learned response but can occur without prior exposure to chemotherapy depending on patient emotional distress and expectations. The best method to avoid development or reinforcement of ANV is to avoid both vomiting and nausea from the first exposure to chemotherapy. If ANV develops, benzodiazepines have been documented to help in adult patients, and several psychological techniques are also of help, including systematic desensitization. The evidence on which these conclusions are based is reviewed in this article.


Anticipatory nausea and vomiting 


  1. 1.
    Aapro MS, Kirchner V, Terrey JP (1994) The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron. Br J Cancer 69:957–960PubMedGoogle Scholar
  2. 2.
    Andrykowski MA, Redd WH, Hatfield AK (1985) Development of anticipatory nausea: a prospective analysis. J Consult Clin Psychol 53:447–454CrossRefPubMedGoogle Scholar
  3. 3.
    Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) (1998) Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Ann Oncol 9:811–819CrossRefPubMedGoogle Scholar
  4. 4.
    Burish TG, Shartner CD, Lyles JN (1981) Effectiveness of multiple muscle-site EMG biofeedback and relaxation training in reducing the aversiveness of cancer chemotherapy. Biofeedback Self Regul 6:523–535PubMedGoogle Scholar
  5. 5.
    Carey MP, Burish TG (1988) Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bull 104:307–325CrossRefPubMedGoogle Scholar
  6. 6.
    Collins KB, Thomas DJ (2004) Acupuncture and acupressure for the management of chemotherapy-induced nausea and vomiting. J Am Acad Nurse Pract 16:76–80Google Scholar
  7. 7.
    Davey VA, Biederman GB (1998) Conditioned antisickness: indirect evidence from rats and direct evidence from ferrets that conditioning alleviates drug-induced nausea and emesis. J Exp Psychol Anim Behav Process 24:483–491CrossRefPubMedGoogle Scholar
  8. 8.
    Fernandez-Marcos A, Martin M, Sanchez JJ, Rodriguez-Lescure A, Casado A, Lopez Martin JA, Diaz-Rubio E (1996) Acute and anticipatory emesis in breast cancer patients. Support Care Cancer 4:370–377PubMedGoogle Scholar
  9. 9.
    Fetting JH, Sheidler VR, Stefanek ME, et al (1987) Clonidine for anticipatory nausea and vomiting: a pilot study examining dose-toxicity relationships and potential for further study. Cancer Treat Rep 71:409–410PubMedGoogle Scholar
  10. 10.
    Gulhas N, Turkoz A, Durmus M, Togal T, Gedik E, Ersoy MO (2003) Oral clonidine premedication does not reduce postoperative vomiting in children undergoing strabismus surgery. Acta Anaesthesiol Scand 47:90–93CrossRefPubMedGoogle Scholar
  11. 11.
    Hickok JT, Roscoe JA, Morrow GR (2001) The role of patients’ expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage 22:843–850CrossRefPubMedGoogle Scholar
  12. 12.
    Hursti T, Fredrikson M, et al (1992) Association between personality characteristics and the prevalence and extinction of conditioned nausea after chemotherapy. J Psychosoc Oncol 10:59–77Google Scholar
  13. 13.
    Kim Y, Morrow GR (2003) Changes in family relationships affect the development of chemotherapy-related nausea symptoms. Support Care Cancer 11:171–177PubMedGoogle Scholar
  14. 14.
    Lett BT (1983) Pavlovian drug-sickness pairings result in the conditioning of an antisickness response. Behav Neurosci 97:779–784CrossRefPubMedGoogle Scholar
  15. 15.
    Malik IA, Khan WA, Qazilbash M, Ata E, Butt A, Khan MA (1995) Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 18:170–175PubMedGoogle Scholar
  16. 16.
    Marchioro G, Azzarello G, Viviani F, Barbato F, Pavanetto M, Rosetti F, Pappagallo GL, Vinante O (2000) Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology 59:100–104CrossRefPubMedGoogle Scholar
  17. 17.
    Matteson, S, Roscoe J, Hickok J, Morrow GR (2002) The role of behavioral conditioning in the development of nausea. Am J Obstet Gynecol 185 [5 Suppl]:S239–S243Google Scholar
  18. 18.
    Mayer DJ (2000) Acupuncture: an evidence-based review of the clinical literature. Annu Rev Med 51:49–63CrossRefPubMedGoogle Scholar
  19. 19.
    Molassiotis A (1999) Further evaluation of a scale to screen for risk of emotional difficulties in bone marrow transplant recipients. J Adv Nurs 29:922–927CrossRefPubMedGoogle Scholar
  20. 20.
    Molassiotis A, Yung HP, Yam BM, Chan FY, Mok TS (2002) The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer 10:237–246CrossRefPubMedGoogle Scholar
  21. 21.
    Montgomery GH, Bovbjerg DH (2003) Expectations of chemotherapy-related nausea: emotional and experiential predictors. Ann Behav Med 25:48–54CrossRefPubMedGoogle Scholar
  22. 22.
    Morrow GR (1984) Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol 2:1170–1176PubMedGoogle Scholar
  23. 23.
    Morrow GR, Rosenthal SN (1996) Models, mechanisms and management of anticipatory nausea and emesis. Oncology 53 [Suppl 1]:4–7Google Scholar
  24. 24.
    Morrow GR, Lindke J, Black PM (1991) Predicting development of anticipatory emesis in cancer patients: prospective examination of eight characteristics. J Pain Symptom Manage 6:215–223CrossRefPubMedGoogle Scholar
  25. 25.
    Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ (1998) Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer 6:244–247CrossRefPubMedGoogle Scholar
  26. 26.
    Mundy EA, DuHamel KN, Montgomery GH (2003) The efficacy of behavioral interventions for cancer treatment-related side effects. Semin Clin Neuropsychiatr 8:253–275Google Scholar
  27. 27.
    Oddby-Muhrbeck E, Eksborg S, Bergendahl HT, Muhrbeck O, Lonnqvist PA (2002) Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology 96:1109–1114CrossRefPubMedGoogle Scholar
  28. 28.
    Parker LA, Kemp SW (2001) Tetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus: an animal model of anticipatory nausea and vomiting (ANV). Neuroreport 12:749–7 51CrossRefPubMedGoogle Scholar
  29. 29.
    Raynaud G (1995) Current status of the activity of 5-HT3 receptor antagonists in animal pharmacology. Ann Pharm Fr 53:19–23PubMedGoogle Scholar
  30. 30.
    Razavi D, Delvaux N, Farvacques C, et al (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384–1390PubMedGoogle Scholar
  31. 31.
    Redd WH, Andresen GV, Minagawa RY (1982) Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy. J Consult Clin Psychol 50:14–19CrossRefPubMedGoogle Scholar
  32. 32.
    Redd WH, Montgomery GH, DuHamel KN (2001) Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 93:810–823CrossRefPubMedGoogle Scholar
  33. 33.
    Stockhorst U, Klosterhalfen S, Klosterhalfen W, Winkelmann M, Steingrueber HJ (1993) Anticipatory nausea in cancer patients receiving chemotherapy: classical conditioning etiology and therapeutical implications. Integr Physiol Behav Sci 28:177–181PubMedGoogle Scholar
  34. 34.
    Stockhorst U, Wiener JA, Klosterhalfen S, Klosterhalfen W, Aul C, Steingruber HJ (1998) Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiol Behav 64:743–753CrossRefPubMedGoogle Scholar
  35. 35.
    Stockhorst U, Spennes-Saleh S, Korholz D, Gobel U, Schneider ME, Steingruber HJ, Klosterhalfen S (2000) Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: features of a classically conditioned response? Brain Behav Immun 14:198–218CrossRefPubMedGoogle Scholar
  36. 36.
    Vasterling J, Jenkins RA, Tope DM, Burish TG (1993) Cognitive distraction and relaxation training for the control of side effects due to cancer chemotherapy. J Behav Med 16:65–80PubMedGoogle Scholar
  37. 37.
    Watson M, Meyer L, Thomson A, Osofsky S (1998) Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer 34:831–837CrossRefPubMedGoogle Scholar
  38. 38.
    Weddington WW, Miller NJ, Sweet DL (1984) Anticipatory nausea and vomiting associated with cancer chemotherapy. J Psychosom Res 28:73–77CrossRefPubMedGoogle Scholar
  39. 39.
    Wilcox PM, Fetting JH, Nettesheim KM, Abeloff MD (1982) Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 66:1601–1604PubMedGoogle Scholar
  40. 40.
    Yugin L (1989) Treating patients with nervous vomiting in the dental office by point-stimulating therapy. Spec Care Dentist 9:27–28PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Matti S. Aapro
    • 1
    Email author
  • Alexander Molassiotis
    • 2
  • Ian Olver
    • 3
  1. 1.IMO Clinique de GenolierGenolierSwitzerland
  2. 2.School of NursingUniversity of ManchesterManchesterUK
  3. 3.Cancer CenterRoyal Adelaide HospitalAdelaideAustralia

Personalised recommendations